Arjan Boltjes<p>"These data identify developmental lineage as a key determinant of sensitivity to anti-GD2 based immunotherapies and credential <a href="https://mastodon.social/tags/EZH2" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>EZH2</span></a> inhibitors for clinical testing in combination with anti-GD2 antibody to enhance outcomes for children with <a href="https://mastodon.social/tags/neuroblastoma" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>neuroblastoma</span></a>".</p><p>An article that I had missed, by Mabe et al., linking <a href="https://mastodon.social/tags/mesenchymal" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>mesenchymal</span></a> <a href="https://mastodon.social/tags/tumour" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>tumour</span></a> cell state, <a href="https://mastodon.social/tags/GD2" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>GD2</span></a> expression, <a href="https://mastodon.social/tags/ST8SIA1" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ST8SIA1</span></a> expression, and <a href="https://mastodon.social/tags/immunotherapy" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>immunotherapy</span></a> <a href="https://mastodon.social/tags/TherapyResistance" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>TherapyResistance</span></a>. </p><p><a href="https://www.nature.com/articles/s43018-022-00405-x" rel="nofollow noopener" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">nature.com/articles/s43018-022</span><span class="invisible">-00405-x</span></a></p><p>Sadly, not open access.</p>